Structurally characterized gallium-chrysin complexes with anticancer potential

Area of Science:

• Medicinal Chemistry
• Inorganic Chemistry
• Biochemistry

Background:

• Metal-based chemotherapeutics offer anticancer efficacy but face limitations due to toxicity.
• Natural products, particularly flavonoids, present a promising alternative for developing novel anticancer agents.
• Flavonoids can serve as ligands to create bioactive metal complexes with enhanced therapeutic properties.

Purpose of the Study:

• To synthesize and characterize novel gallium(III) complexes incorporating the flavonoid chrysin.
• To investigate the anticancer potential and mechanism of action of these new metal-flavonoid complexes.
• To explore the structure-activity relationship of Ga(iii) complexes with different ancillary ligands.

Main Methods:

• Synthesis of three novel Ga(iii) complexes with chrysin and ancillary ligands (1,10-phenanthroline, 2,2'-bipyridine, imidazole).
• Detailed structural and physicochemical characterization using crystallographic and spectroscopic techniques.
• In vitro cytotoxicity evaluation against various cancer cell lines and assessment of reactive oxygen species (ROS) generation.

Main Results:

• Successful synthesis and full characterization of three unique Ga(iii)-flavonoid complexes.
• The complexes demonstrated significant in vitro cytotoxicity against a panel of cancer cell lines.
• The Ga(iii)-chrysin-imidazole complex exhibited superior anticancer efficacy, with IC50 values below 1.18 μM and notable ROS generation.

Conclusions:

• Novel Ga(iii) complexes with chrysin and ancillary ligands were successfully synthesized and characterized.
• These complexes display promising anticancer activity and ROS-generating potential in vitro.
• The Ga(iii)-chrysin-imidazole complex warrants further investigation as a potential lead compound for anticancer drug development.